Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537360 | Vaccine | 2016 | 8 Pages |
Abstract
Taken together, the vaccine candidate effectively generates persistent and anamnestic antibody response, elicits participation of CD4+ memory T cells and triggers memory B cells to differentiate into ASCs upon boosting. This approach of assessing the immunogenicity of vaccine candidate could be useful to explore the longevity of HEV-specific memory response in future HEV vaccine trials in human.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Shruti P. Kulkarni, Subrat Thanapati, Vidya A. Arankalle, Anuradha S. Tripathy,